| Homocysteine is lower in the third trimester of pregnancy in women with enhanced folate status from continued folic acid supplementation. | |
| | |
MedLine Citation:
|
PMID: 15615817 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
BACKGROUND: In many countries, current recommendations are that women take a daily 400-mug folic acid supplement from before conception until the end of the 12th week of gestation for the prevention of neural tube defects. Low folate status is associated with an increased concentration of plasma total homocysteine (tHcy), a risk factor associated with pregnancy complications such as preeclampsia. METHODS: In a longitudinal study, we determined tHcy and corresponding folate status in 101 pregnant women at 12, 20, and 35 weeks of gestation, in 35 nonpregnant controls sampled concurrently, and in a subgroup (n = 21 pregnant women and 19 nonpregnant controls) at 3 days postpartum. RESULTS: Plasma tHcy was significantly lower throughout pregnancy compared with nonpregnant controls, with values lowest in the second trimester before increasing toward nonpregnant values in the third trimester. Importantly, mean tHcy concentrations were lower in pregnant women taking folic acid supplements than in those not, an effect that reached significance in the third trimester (5.45 vs 7.40 micromol/L; P <0.05). During the third trimester, tHcy concentrations were significantly higher in pregnant women with a history of miscarriage than in women with no previous history (8.15 vs 6.38 micromol/L; P <0.01). CONCLUSIONS: This is the first longitudinal study to show that homocysteine concentrations increase in late pregnancy toward nonpregnant values; an increase that can be limited by enhancing folate status through continued folic acid supplementation. These results indicate a potential role for continued folic acid supplementation in reducing pregnancy complications associated with hyperhomocysteinemia. |
| | |
Authors:
|
Valerie A Holmes; Julie M W Wallace; H Denis Alexander; William S Gilmore; Ian Bradbury; Mary Ward; John M Scott; Peter McFaul; Helene McNulty |
Related Documents
:
|
12803847 - Vitamin a deficiency presenting as night blindness during pregnancy. 18335097 - Nutritional status has marginal influence on the metabolism of inorganic arsenic in pre... 1685367 - Nutritional implications for nitrogen and mineral budgets from analysis of guano of the... 11375437 - New perspectives on folate catabolism. 6794297 - Possible synthesis of pregnancy-'specific' beta-1-glycoprotein (sp1) and placenta-'spec... 9494917 - The diagnostic value of interleukin-8 and fetal fibronectin concentrations in cervical ... |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't Date: 2004-12-22 |
Journal Detail:
|
Title: Clinical chemistry Volume: 51 ISSN: 0009-9147 ISO Abbreviation: Clin. Chem. Publication Date: 2005 Mar |
Date Detail:
|
Created Date: 2005-03-01 Completed Date: 2005-04-11 Revised Date: 2006-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 9421549 Medline TA: Clin Chem Country: United States |
Other Details:
|
Languages: eng Pagination: 629-34 Citation Subset: IM |
Affiliation:
|
Northern Ireland Centre for Food and Health (NICHE), School of Biomedical Sciences, University of Ulster, Coleraine, UK. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adolescent Adult Dietary Supplements* Female Folic Acid / administration & dosage, blood* Homocysteine / blood* Humans Longitudinal Studies Pregnancy Pregnancy Trimester, Third |
| Chemical | |
Reg. No./Substance:
|
454-28-4/Homocysteine; 59-30-3/Folic Acid |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Biomarker responses during and after treatment with nesiritide infusion in patients with decompensat...
Next Document: Molecular pathogenesis of euthyroid and toxic multinodular goiter.